Patient provider profile for Dr. David Hockenbery, board-certified gastroenterologist at Fred Hutchinson Cancer Center.

Dr. David Hockenbery is a clinical researcher who studies the biology of programmed cell death, or apoptosis, the process by which cells commit suicide when diseased or no longer needed. His research focuses on cell-death processes that are defective in many cancer cells, allowing them to grow unchecked.

David M. Hockenbery M.D. Accepting new and returning patients Please call to schedule an appointment with this provider.

2023年3月1日 · November 15, 1976 - February 10, 2023 (46 years old) It is with great sadness that we announce the death of David Hockenberry (Johnstown, Pennsylvania), who passed away on February 10, 2023, at the age of 46, leaving to mourn family and friends.

2022年6月8日 · David E. Hockenberry, 72, formerly of Newport and Millersburg, passed away Tuesday, June 7, 2022 Services will be held Saturday, June 11, 2022, at 11:00 am from Reigles Bible Fellowship Church,...

Dr. David M. Hockenbery is a gastroenterologist in Seattle, Washington and is affiliated with multiple hospitals in the area, including UW Medicine-University of Washington Medical Center and...

2022年7月1日 · El Paso, Texas - David A. Hockenberry, May 1, 1948 â€" June 16, 2022 â€" David A. Hockenberry, 74 of El Paso, Texas was born in Bellefonte, PA. He was raised by his grandmother, Gwenn...

2022年4月13日 · Gastroenterologist Dr. David Hockenbery is this year’s recipient of the Dr. Ali Al-Johani Award, which is given to recognize individuals at Fred Hutchinson Cancer Research Center who provide exceptional medical care and compassion for their patients.

David E. Hockenberry, 72, of Lewisburg formerly of Newport, passed away peacefully Tuesday night, June 7, 2022 at Riverside Health Care and Rehab Center, Taylor, PA. Born and raised in Millersburg, on May 8, 1950, a son of the late Paul and Mary Rowe Hockenberry.

Dr. Hockenbery believes that cellular re-programming to a stem cell-like state, one of the hallmarks of cancer, provides a clue about how cancer cells might lose the ability to present these antigens.